Latest Observability News

Immuron has submitted its Phase 2 clinical study report for Travelan® to the FDA, revealing statistically significant immunological and microbiome benefits. The company is preparing to engage the FDA for Phase 3 trial discussions while progressing a large field study with military personnel.

Skylark Minerals has confirmed highly favourable geology for base metal mineralisation at its Narongo Prospect within the Captains Flat Project, identifying new drill targets and planning further exploration activities for 2025.

Element 25 has obtained key regulatory approval from WA's DEMIRS for its Butcherbird Expansion Project, paving the way for a twelve-year production run at 1.1 million tonnes per annum of manganese concentrate. The final hurdle remains the Works Approval, expected imminently.

Chilwa Minerals has reported compelling geochemical results from initial soil sampling at its Lake Chilwa project, revealing significant concentrations of niobium and rare earth elements. These findings bolster the company's dual exploration strategy and set the stage for accelerated drilling campaigns.

Raiden Resources has reported promising high-grade lithium mineralisation in its maiden drilling at Andover South, while identifying a potentially larger, untested Southern Corridor target for future exploration.

EBR Systems Inc. has responded to ASX's price query, denying any undisclosed information behind recent trading spikes and confirming compliance with listing rules. The company also flagged an upcoming FDA inspection announcement.